These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26927848)

  • 1. CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Olsson KM; Olle S; Fuge J; Welte T; Hoeper MM; Lerch C; Maegel L; Haller H; Jonigk D; Schiffer L
    Respir Res; 2016 Feb; 17():21. PubMed ID: 26927848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [End tidal PCO(2) for evaluation of severity of disease in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension].
    Shi X; Yang GL; Chen Y; Guo J; Yang WL; Yuan P; Gong SG; Jiang R; Zhao QH; Wang L; He J; Chen TX; Liu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Jan; 40(1):34-39. PubMed ID: 28100360
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.
    Chen G; Yang T; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; He JG; Xiong CM
    Respirology; 2014 May; 19(4):608-15. PubMed ID: 24689969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Peripheral small airway dysfunction differences between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension].
    An QY; Jiang R; Wang L; Zhao QH; Gong SG; He J; Luo CJ; Liu MQ; Qiu HL; Guo J; Liu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Dec; 41(12):934-941. PubMed ID: 30522190
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-tuberculous mycobacterial lung disease (NT MLD ) in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension.
    Wilińska E; Oniszh K; Augustynowicz-Kopeć E; Zabost A; Fijałkowska A; Kurzyna M; Wieteska M; Torbicki A; Kuś J; Szturmowicz M
    Pneumonol Alergol Pol; 2014; 82(6):495-502. PubMed ID: 25339559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry].
    Chazova IE; Valieva ZS; Nakonechnikov SN; Taran IN; Martynyuk TV
    Ter Arkh; 2019 Sep; 91(9):77-87. PubMed ID: 32598818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension. A case-control study.
    Lang IM; Simonneau G; Pepke-Zaba JW; Mayer E; Ambrož D; Blanco I; Torbicki A; Mellemkjaer S; Yaici A; Delcroix M
    Thromb Haemost; 2013 Jul; 110(1):83-91. PubMed ID: 23677493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen uptake is more efficient in idiopathic pulmonary arterial hypertension than in chronic thromboembolic pulmonary hypertension.
    Shi X; Guo J; Gong S; Sapkota R; Yang W; Liu H; Xiang W; Wang L; Sun X; Liu J
    Respirology; 2016 Jan; 21(1):149-56. PubMed ID: 26390972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma 15-F2t-isoprostane in idiopathic pulmonary arterial hypertension.
    Zhang R; Sun ML; Fan YF; Jiang X; Zhao QH; He J; Wang L; Shailendra PK; Safdar Z; Jing ZC
    Int J Cardiol; 2014 Aug; 175(2):268-73. PubMed ID: 24877587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct bilirubin: A new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension.
    Xu XQ; Lv ZC; Liu QQ; Zhao QH; Wu Y; Sun K; Jiang X; Wang L; Peng FH; Jing ZC
    Int J Cardiol; 2017 Feb; 228():895-899. PubMed ID: 27894061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH.
    Moser B; Megerle A; Bekos C; Janik S; Szerafin T; Birner P; Schiefer AI; Mildner M; Lang I; Skoro-Sajer N; Sadushi-Kolici R; Taghavi S; Klepetko W; Ankersmit HJ
    PLoS One; 2014; 9(9):e106440. PubMed ID: 25188497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients.
    Zabini D; Heinemann A; Foris V; Nagaraj C; Nierlich P; Bálint Z; Kwapiszewska G; Lang IM; Klepetko W; Olschewski H; Olschewski A
    Eur Respir J; 2014 Oct; 44(4):951-62. PubMed ID: 25034560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical usefulness of end-tidal CO
    Ramos RP; Ferreira EVM; Valois FM; Cepeda A; Messina CMS; Oliveira RK; Araújo ATV; Teles CA; Neder JA; Nery LE; Ota-Arakaki JS
    Respir Med; 2016 Nov; 120():70-77. PubMed ID: 27817818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentraxin3 in chronic thromboembolic pulmonary hypertension: a new biomarker for screening from remitted pulmonary thromboembolism.
    Naito A; Tanabe N; Jujo T; Shigeta A; Sugiura T; Sakao S; Ishida K; Tatsumi K
    PLoS One; 2014; 9(11):e113086. PubMed ID: 25412085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.
    Vuga LJ; Tedrow JR; Pandit KV; Tan J; Kass DJ; Xue J; Chandra D; Leader JK; Gibson KF; Kaminski N; Sciurba FC; Duncan SR
    Am J Respir Crit Care Med; 2014 Apr; 189(8):966-74. PubMed ID: 24628285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial Hypertension.
    Wetzl V; Tiede SL; Faerber L; Weissmann N; Schermuly RT; Ghofrani HA; Gall H
    Lung; 2017 Aug; 195(4):489-496. PubMed ID: 28516393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between High FSH, Low Progesterone, and Idiopathic Pulmonary Arterial Hypertension in Women of Reproductive Age.
    Zhang YX; Wang L; Lu WZ; Yuan P; Wu WH; Zhou YP; Zhao QH; Zhang SJ; Li Y; Wu T; Jiang X; Jing ZC
    Am J Hypertens; 2020 Jan; 33(1):99-105. PubMed ID: 31504137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red cell distribution width is increased in chronic thromboembolic pulmonary hypertension.
    Wang W; Liu J; Yang YH; Zhai ZG; Wang C; Wang J
    Clin Respir J; 2016 Jan; 10(1):54-60. PubMed ID: 24989160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients.
    Scheidl SJ; Englisch C; Kovacs G; Reichenberger F; Schulz R; Breithecker A; Ghofrani HA; Seeger W; Olschewski H
    Eur Respir J; 2012 Jan; 39(1):119-24. PubMed ID: 21737552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014.
    Rådegran G; Kjellström B; Ekmehag B; Larsen F; Rundqvist B; Blomquist SB; Gustafsson C; Hesselstrand R; Karlsson M; Kornhall B; Nisell M; Persson L; Ryftenius H; Selin M; Ullman B; Wall K; Wikström G; Willehadson M; Jansson K;
    Scand Cardiovasc J; 2016 Aug; 50(4):243-50. PubMed ID: 27146648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.